InvestorsHub Logo
Followers 144
Posts 8676
Boards Moderated 0
Alias Born 10/07/2013

Re: Whalatane post# 81536

Monday, 05/30/2016 10:23:50 AM

Monday, May 30, 2016 10:23:50 AM

Post# of 423944
K-

Remember JELIS was an Open Label trial (more vulnerable to bias ) with a heavy reliance on reported Angina.
Thats why I prefer to look at the hard numbers for MI and Intervention in JELIS ..not the total numbers

??? I am not aware of any data / table (aka breakdown) for MI and Intervention other than for the total.

It sound like you are mixing the "Cardiovascular history" (at baseline) with "Major coronary events" (during the study).

e.g.

Among the 1,050 patients with prior MI, the incidence of MCE in the EPA group (15.0%) was significantly lower than that in the control group (20.1%, adjusted HR 0.73, P=0.033, NNT =19)

The 15.0% and 20.1% had a heavy reliance on reported Angina, most of it were Angina.

Best,
G

#STRONGERTOGETHER

Disclosure: I am long with this stock. I wrote this post myself, and it expresses my own opinions (IMHO). I am not receiving compensation for it.

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AMRN News